可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Chugh SS,Havmoeller R,Narayanan K,et al.Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study[J].Circulation,2014,129(8):837-847.
[2]Marijon E,Le Heuzey JY,Connolly S,et al.Causes of death and influencing factors in patients with atrial fibrillation:a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study[J].Circulation,2013,128(20):2192-2201.
[3]Kirchhof P,Breithardt G,Camm AJ,et al.Improving outcomes in patients with atrial fibrillation:rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial[J].Am Heart J,2013,166(3):442-448.
[4]马长生.房颤诊疗终身管理[J].中国医院院长,2013(19):72-73.
[5]张 莲,殷春悦,胡善联.我国心房纤颤的疾病负担[J].中国卫生经济,2013(12):5-7.
[6]January CT,Wann LS,Alpert JS,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J].J Am Coll Cardiol,2014,64(21):e1-e76.
[7]Kirchhof P,Breithardt G,Bax J,et al.A roadmap to improve the quality of atrial fibrillation management:proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference[J].Europace,2016,18(1):37-50.
[8]Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS:The Task Force for the management of atrial fibrillation of the European Society of Cardiology(ESC)Developed with the special contribution of the European Heart Rhythm Association(EHRA)of the ESC Endorsed by the European Stroke Organisation(ESO)[J].Cor et Vasa,2016,58(6):s e636-e683.
[9]Leyden JM,Kleinig TJ,Newbury J,et al.Adelaide stroke incidence study:declining stroke rates but many preventable cardioembolic strokes[J].Stroke,2013,44(5):1226-1231.
[10]Hannon N,Sheehan O,Kelly L,et al.Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study[J].Cerebrovasc Dis,2010,29(1):43-49.
[11]Friberg L,Rosenqvist M,Lindgren A,et al.High prevalence of atrial fibrillation among patients with ischemic stroke[J].Stroke,2014,45(9):2599-2605.
[12]Sposato LA,Cipriano LE,Saposnik G,et al.Diagnosis of atrial fibrillation after stroke and transient ischaemic attack:a systematic review and meta-analysis[J].Lancet Neurol,2015,14(4):377-387.
[13]Lowres N,Neubeck L,Redfern J,et al.Screening to identify unknown atrial fibrillation.A systematic review[J].Thromb Haemost,2013,110(2):213-222.
[14]Engdahl J,Andersson L,Mirskaya M,et al.Stepwise screening of atrial fibrillation in a 75-year-old population:implications for stroke prevention[J].Circulation,2013,127(8):930-937.
[15]Lowres N,Neubeck L,Salkeld G,et al.Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study[J].Thromb Haemost,2014,111(6):1167-1176.
[16]Tieleman RG,Plantinga Y,Rinkes D,et al.Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation[J].Europace,2014,16(9):1291-1295.
[17]Aronsson M,Svennberg E,Rosenqvist M,et al.Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording[J].Europace,2015,1 7(7):1023-1029.
[18]Al-Khatib SM,Allen LN,Chatterjee R,et al.Rate- and rhythm-control therapies in patients with atrial fibrillation:a systematic review[J].Ann Intern Med,2014,160(11):760-773.
[19]Zhu W,Wan R,Liu F,et al.Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review[J].J Am Heart Assoc,2016,5(9).pii:e004006.doi:10.1161/JAHA.116.004006.
[20]Karason K,Molgaard H,Wikstrand J,et al.Heart rate variability in obesity and the effect of weight loss[J].Am J Cardiol,1999,83(8):1242-1247.
[21]Russo C,Jin Z,Homma S,et al.Effect of obesity and overweight on left ventricular diastolic function:a community-based study in an elderly cohort[J].J Am Coll Cardiol,2011,57(12):1368-1374.
[22]Visser M,Bouter LM,McQuillan GM,et al.Elevated C-reactive protein levels in overweight and obese adults[J].JAMA,1999,282(22):2131-2135.
[23]Overvad TF,Rasmussen LH,Skjoth F,et al.Body mass index and adverse events in patients with incident atrial fibrillation[J].Am J Med,2013,126(7):640-649.
[24]Abed HS,Wittert GA,Leong DP,et al.Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation:a randomized clinical trial[J].JAMA,2013,310(19):2050-2060.
[25]蒋 捷.心房颤动患者长期管理——房颤中心的临床实践[J].中国介入心脏病学杂志,2016(03):179-180.
[26]Berti D,Hendriks JM,Brandes A,et al.A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice[J].Eur Heart J,2013,34(35):2725-2730.
[27]Nieuwlaat R,Olsson SB,Lip GY,et al.Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation.The Euro Heart Survey on Atrial Fibrillation[J].Am Heart J,2007,153(6):1006-1012.
[28]Lorig KR,Holman H.Self-management education:history,definition,outcomes, and mechanisms[J].Ann Behav Med,2003,26(1):1-7.
[29]Stiggelbout AM,Van der Weijden T,De Wit MP,et al.Shared decision making:really putting patients at the centre of healthcare[J].BMJ,2012,344:e256.
[30]Camm AJ,Lip GY,De Caterina R,et al.2012 focused update of the ESC Guidelines for the management of atrial fibrillation:an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association[J].Europace,2012,14(10):1385-1413.
[31]Camm AJ,Kirchhof P,Lip GY,et al.Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J].Europace,2010,12(10):1360-1420.
[32]Potpara TS,Pison L,Larsen TB,et al.How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey[J].Europace,2015,17(3):468-472.
[33]Seaburg L,Hess EP,Coylewright M,et al.Shared decision making in atrial fibrillation:where we are and where we should be going[J].Circulation,2014,129(6):704-710.
[34]Lane DA,Aguinaga L,Blomstrom-Lundqvist C,et al.Cardiac tachyarrhythmias and patient values and preferences for their management:the European Heart Rhythm Association(EHRA)consensus document endorsed by the Heart Rhythm Society(HRS),Asia Pacific Heart Rhythm Society (APHRS),and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia(SOLEACE)[J].Europace,2015,17(12):1747-1769.
[35]Nuno R,Coleman K,Bengoa R,et al.Integrated care for chronic conditions:the contribution of the ICCC Framework[J].Health Policy,2012,105(1):55-64.
[36]Bodenheimer T,Wagner EH,Grumbach K.Improving primary care for patients with chronic illness:the chronic care model,Part 2[J].JAMA,2002,288(15):1909-1914.
[37]McCabe PJ.Self-management of atrial fibrillation:a new frontier for nursing research[J].Prog Cardiovasc Nurs,2008,23(1):37-40.
[38]Calvert M,Thwaites R,Kyte D,et al.Putting patient-reported outcomes on the‘Big Data Road Map’[J].J R Soc Med,2015,108(8):299-303.
[39]Anker SD,Agewall S,Borggrefe M,et al.The importance of patient-reported outcomes:a call for their comprehensive integration in cardiovascular clinical trials[J].Eur Heart J,2014,35(30):2001-2009.
[40]Calvert M,Blazeby J,Altman DG,et al.Reporting of patient-reported outcomes in randomized trials:the CONSORT PRO extension[J].JAMA,2013,309(8):814-822.
[41]Hendriks JM,de Wit R,Crijns HJ,et al.Nurse-led care vs.usual care for patients with atrial fibrillation:results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation[J].Eur Heart J,2012,33(21):2692-2699.